| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0304-3959(97)00049-3 |
| P698 | PubMed publication ID | 9415498 |
| P2093 | author name string | Kingery WS | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuropathic pain | Q2798704 |
| P304 | page(s) | 123-139 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Pain | Q2317902 |
| P1476 | title | A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes | |
| P478 | volume | 73 |
| Q36464466 | "Listening" and "talking" to neurons: implications of immune activation for pain control and increasing the efficacy of opioids |
| Q37805539 | 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review |
| Q48676649 | A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain |
| Q35092327 | A comparison of the pharmacological modulation of hyperalgesia and bronchial hyperresponsiveness. |
| Q36238133 | A proposed algorithm for the management of pain following spinal cord injury. |
| Q24683100 | Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS |
| Q46886099 | Acute and subchronic effects of amitriptyline 25mg on actual driving in chronic neuropathic pain patients |
| Q34246605 | Advances in the management of neuropathic pain. |
| Q37848196 | Advances in translational neuropathic research: example of enantioselective pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief in complex regional pain syndrome |
| Q33542923 | Aggressive pharmacologic treatment of pain |
| Q44369436 | An unusual anaesthetic for a through-knee amputation |
| Q33660769 | Analgesics. Opioids, adjuvants, and others. |
| Q73119742 | Antagonism of the melanocortin system reduces cold and mechanical allodynia in mononeuropathic rats |
| Q37778613 | Anti-inflammatory treatment of Complex Regional Pain Syndrome |
| Q35044029 | Anticonvulsants for the treatment of neuropathic pain syndromes |
| Q52683102 | Antinociceptive effects of novel histamine H3 R and H4 R receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse. |
| Q36811556 | Applied information retrieval and multidisciplinary research: new mechanistic hypotheses in complex regional pain syndrome |
| Q42581693 | Applying salve in complex regional pain syndrome |
| Q48228055 | Avulsion injury of the rat brachial plexus triggers hyperalgesia and allodynia in the hindpaws: a new model for the study of neuropathic pain |
| Q61799631 | Brachial plexus paralysis after thoracoscopic esophagectomy for esophageal cancer in the prone position: A thought-provoking case report of an unexpected complication |
| Q34635953 | Calcitonin in reflex sympathetic dystrophy syndrome and other painful conditions |
| Q36111923 | Cannabinoid-based drugs as anti-inflammatory therapeutics |
| Q43851051 | Capsaicin sensitive afferents mediate the development of heat hyperalgesia and hindpaw edema after sciatic section in rats |
| Q26745591 | Capsaicin: Current Understanding of Its Mechanisms and Therapy of Pain and Other Pre-Clinical and Clinical Uses |
| Q33656168 | Causalgia and reflex sympathetic dystrophy: does the sympathetic nervous system contribute to the generation of pain? |
| Q35962777 | Causes of a painful total knee arthroplasty. Are patients still receiving total knee arthroplasty for extrinsic pathologies? |
| Q33975118 | Cervical Epidural Anaesthesia for Radical Mastectomy and Chronic Regional Pain Syndrome of upper limb-A Case Report |
| Q24198266 | Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome |
| Q24236806 | Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome |
| Q33947001 | Challenges in the development of novel treatment strategies for neuropathic pain |
| Q82028816 | Chapter 25 The autonomic nervous system and pain |
| Q82028895 | Chapter 35 Complex regional pain syndrome |
| Q36022144 | Chronic pain syndromes in the emergency department: identifying guidelines for management |
| Q34081591 | Chronic regional pain syndrome, type 1: Part II. |
| Q21564035 | Complex Regional Pain Syndrome: A Review |
| Q44598870 | Complex regional pain syndrome I and II. What effects the outcome? |
| Q35014400 | Complex regional pain syndrome and chronic pain management in the lower extremity |
| Q38436270 | Complex regional pain syndrome type I: a comprehensive review |
| Q37441726 | Complex regional pain syndrome type I: efficacy of stellate ganglion blockade |
| Q35069548 | Complex regional pain syndrome--diagnostic, mechanisms, CNS involvement and therapy |
| Q35117151 | Complex regional pain syndrome: A review of evidence-supported treatment options |
| Q91768916 | Complex regional pain syndrome: a narrative review for the practising clinician |
| Q35565725 | Complex regional pain syndrome: mystery explained? |
| Q34185085 | Complex regional pain syndromes |
| Q37697878 | Complex regional pain syndromes: new pathophysiological concepts and therapies |
| Q37778432 | Complications of Heel Surgery |
| Q37201586 | Conservative therapy for Complex Regional Pain Syndrome Type I in a paediatric patient: a case study |
| Q24186410 | Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery |
| Q24203809 | Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery |
| Q57689177 | Continuous intravenous perioperative lidocaine infusion for postoperative pain and recovery in adults |
| Q30909251 | Controversies surrounding reflex sympathetic dystrophy: a review article |
| Q34449646 | Corticosteroids and oral surgery |
| Q37230366 | Cost-effectiveness analysis of a lidocaine 5% medicated plaster compared with gabapentin and pregabalin for treating postherpetic neuralgia: a german perspective |
| Q36257216 | Current diagnosis and therapy of complex regional pain syndrome: refining diagnostic criteria and therapeutic options |
| Q36132185 | Current trends in neuropathic pain treatments with special reference to fibromyalgia. |
| Q34795600 | Diabetes mellitus and its chronic complications |
| Q73839591 | Diagnosis and management of neuropathic pain in patients with cancer |
| Q92699232 | Dimethyl Sulfoxide Decreases Levels of Oxylipin Diols in Mouse Liver |
| Q84010093 | Dimethyl sulfoxide induces heme oxygenase-1 expression via JNKs and Nrf2 pathways in human umbilical vein endothelial cells |
| Q37949850 | Dimethyl sulfoxide: an effective penetration enhancer for topical administration of NSAIDs |
| Q34794847 | Does evidence support physiotherapy management of adult Complex Regional Pain Syndrome Type One? A systematic review |
| Q51979702 | Does sympathetic nerve discharge affect the firing of polymodal C-fibre afferents in humans? |
| Q38670319 | Dorsal Root Ganglion Stimulation as a Salvage Treatment for Complex Regional Pain Syndrome Refractory to Dorsal Column Spinal Cord Stimulation: A Case Series |
| Q44901517 | Drug therapy in complex regional pain syndrome type I |
| Q34573607 | EFNS guidelines on pharmacological treatment of neuropathic pain. |
| Q41869183 | Early Treatment of Acute Complex Regional Pain Syndrome after Fracture or Injury with Prednisone: Why Is There a Failure to Treat? A Case Series. |
| Q40774771 | Effective dosage and administration schedule of oral alendronate for non-nociceptive symptoms in rats with chronic constriction injury. |
| Q47738062 | Effects of duloxetine on pain and walking distance in neuropathic pain models via modulation of the spinal monoamine system |
| Q39219762 | Effects of local corticosteroid injection on electrical properties of aβ-fibers in carpal tunnel syndrome. |
| Q36017190 | Effects of silymarin on neuropathic pain and formalin-induced nociception in mice |
| Q43216968 | Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome. |
| Q39784392 | Efficacy and safety of lacosamide in painful diabetic neuropathy |
| Q39388670 | Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study |
| Q46568721 | Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy |
| Q36066028 | Emerging therapies for neuropathic pain |
| Q44120299 | Enhanced release of adenosine in rat hind paw following spinal nerve ligation: involvement of capsaicin-sensitive sensory afferents |
| Q33652221 | Enhancement of Antinociceptive Effect by Co-administration of Amitriptyline and Crocus Sativus in a Rat Model of Neuropathic Pain |
| Q44905607 | Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome |
| Q21261406 | Evidence based guidelines for complex regional pain syndrome type 1 |
| Q34251691 | Evidence for the use of gabapentin in the treatment of diabetic peripheral neuropathy |
| Q38011182 | Evidence-based guideline for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks |
| Q24246017 | Exercise for people with peripheral neuropathy |
| Q33879278 | Forced exercise attenuates neuropathic pain in chronic constriction injury of male rat: an investigation of oxidative stress and inflammation |
| Q38162868 | Fruit flies as a powerful model to drive or validate pain genomics efforts. |
| Q34183586 | Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials |
| Q43732145 | Glucocorticoid inhibition of neuropathic limb edema and cutaneous neurogenic extravasation |
| Q60687160 | Hyperalgesia due to nerve injury: role of neutrophils |
| Q33882003 | Hyperalgesia due to nerve injury: role of prostaglandins |
| Q36484460 | Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies |
| Q46484254 | Ins and outs of neurologic therapy for chronic pain |
| Q43638364 | Interaction of local anaesthetic agents with the endogenous norepinephrine transporter in SH-SY5Y human neuroblastoma cells. |
| Q43906558 | Intercostal nerve block with 5% tetracaine for chronic pain syndromes |
| Q24197979 | Interventions for treating pain and disability in adults with complex regional pain syndrome- an overview of systematic reviews |
| Q44589931 | Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain |
| Q43512931 | Lack of stereoselectivity for the antiallodynic effect of mexiletine in spinally injured rats |
| Q30427175 | Local anesthetic inhibits hyperpolarization-activated cationic currents |
| Q37140716 | MAPK Pathways Are Involved in Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion. |
| Q49123099 | Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain |
| Q38240995 | Mechanism-based treatment in complex regional pain syndromes |
| Q37386521 | Memantine (Namenda) for neuropathic pain. |
| Q43128920 | Merits of publishing a negative and prematurely ended study on intrathecal methylprednisolone for severe and longstanding complex regional pain syndrome (CRPS-I). |
| Q48785460 | Mexiletine. A review of its therapeutic use in painful diabetic neuropathy |
| Q43243998 | Minocycline potentiates the anti-hyperalgesic effect of ceftriaxone in CCI-induced neuropathic pain in rats |
| Q35093892 | Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects |
| Q73238889 | Neurologic Complications of Cancer Therapy |
| Q26860768 | Neuropathic pain in hereditary peripheral neuropathy |
| Q33661273 | Neuropathic pain: aetiology, symptoms, mechanisms, and management |
| Q36527054 | Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome |
| Q33900381 | Neurophysiology of cancer pain |
| Q90342576 | Neurosteroids and neuropathic pain management: Basic evidence and therapeutic perspectives |
| Q35140851 | Neurotrophic factors as novel therapeutics for neuropathic pain |
| Q36327294 | New Concepts in Complex Regional Pain Syndrome |
| Q35563469 | Nonopioid and adjuvant analgesics in chronic pain management: strategies for effective use |
| Q37688035 | Opioids for the treatment of chronic non-cancer pain in older people |
| Q41883103 | Opposing effects of spinal nerve ligation on calcium-activated potassium currents in axotomized and adjacent mammalian primary afferent neurons. |
| Q74318698 | Outcomes in perioperative medicine and anesthesiology. Into the next millennium |
| Q33931977 | Pain and symptom control in terminally ill children |
| Q34171491 | Pain in nursing home residents: management strategies |
| Q35103462 | Pain management in older adults |
| Q34761368 | Palliative care of the chronically critically ill patient |
| Q34185107 | Pathophysiologic mechanisms of neuropathic pain |
| Q34282592 | Pharmacologic management of pain: the surgeon's responsibility. |
| Q34038997 | Pharmacologic therapies for complex regional pain syndrome |
| Q24657295 | Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society |
| Q37907386 | Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature |
| Q36739954 | Pharmacotherapy for neuropathic pain |
| Q36817054 | Pharmacotherapy options for complex regional pain syndrome |
| Q35888354 | Population analyses of efficacy and safety of ABT-594 in subjects with diabetic peripheral neuropathic pain |
| Q36711173 | Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management |
| Q53169018 | Poststroke Complex Regional Pain Syndrome |
| Q37428626 | Potential Use of Dimethyl Sulfoxide in Treatment of Infections Caused by Pseudomonas aeruginosa. |
| Q35062103 | Potential risk factors for the onset of complex regional pain syndrome type 1: a systematic literature review |
| Q46905360 | RETRACTED: The incidence of complex regional pain syndrome after fasciectomy for Dupuytren's contracture: a prospective observational study of four anesthetic techniques |
| Q48720559 | Recent trends in understanding and therapy of complex regional pain syndromes |
| Q59809045 | Recovery from acute pediatric complex regional pain syndrome type I after ankle sprain by early pharmacological and physical therapies in primary care: a case report |
| Q81075901 | Reflex sympathetic dystrophy and causalgia |
| Q30783851 | Response characteristics of cutaneous mechanoreceptors in neuropathic rats |
| Q39394854 | Response of neuropathic trigeminal pain to the combination of low-dose nalbuphine plus naloxone in humans. |
| Q92702296 | Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain |
| Q30376747 | Short-Term Functional, Emotional, and Pain Outcomes of Patients with Complex Regional Pain Syndrome Treated in a Comprehensive Interdisciplinary Pain Management Program. |
| Q33194572 | Spinal Cord Stimulation for Complex Regional Pain Syndrome: An Evidence-Based Medicine Review of the Literature |
| Q39365363 | Spinal cord stimulation in sympathetically maintained complex regional pain syndrome type I with severe disability. A prospective clinical study |
| Q33846024 | Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial |
| Q39703211 | Steroids, spinal cord and pain sensation. |
| Q34540130 | Successful management of complex regional pain syndrome type 1 using single injection interscalene brachial plexus block |
| Q37154511 | Summary measures of number needed to treat: how much clinical guidance do they provide in neuropathic pain? |
| Q45731639 | Suppression of adrenal gland-derived epinephrine enhances the corticosterone-induced antinociceptive effect in the mouse formalin test |
| Q45181961 | Surgery on the affected upper extremity of patients with a history of complex regional pain syndrome: the use of intravenous regional anesthesia with clonidine |
| Q30779824 | Sympathetic dysfunction as a temporary phenomenon in acute posttraumatic CRPS I. |
| Q42429973 | Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain |
| Q79300961 | Systemic morphine in combination with TENS produces an increased antihyperalgesia in rats with acute inflammation |
| Q30424160 | TASK Channel Deletion Reduces Sensitivity to Local Anesthetic-induced Seizures |
| Q26853270 | Targeting novel peripheral mediators for the treatment of chronic pain |
| Q52312548 | The Rodent Tibia Fracture Model: A Critical Review and Comparison with the Complex Regional Pain Syndrome Literature. |
| Q39414996 | The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system |
| Q51452001 | The effect of repeated epidural sympathetic nerve block on "failed back surgery syndrome" associated chronic low back pain. |
| Q44511907 | The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. |
| Q48284194 | The induction of pain: an integrative review |
| Q35064423 | The pathogenesis and management of painful diabetic neuropathy: a review |
| Q38219855 | The postoperative management of pain from intracranial surgery in pediatric neurosurgical patients |
| Q34074622 | The role of radiofrequency in the management of complex regional pain syndrome |
| Q37706615 | Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain |
| Q40484484 | Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials |
| Q37709505 | Transient receptor potential channels in pain and inflammation: therapeutic opportunities |
| Q39444497 | Traumatic neuralgias: complex regional pain syndromes (reflex sympathetic dystrophy and causalgia): clinical characteristics, pathophysiological mechanisms and therapy |
| Q34568380 | Treatment of complex regional pain syndrome type I. |
| Q46621775 | Treatment of early complex regional pain syndrome type 1 by a combination of mannitol and dexamethasone. |
| Q38329620 | Treatment of painful diabetic peripheral neuropathy |
| Q43856838 | Treatment of painful sensory neuropathy with tiagabine: a pilot study |
| Q39418017 | Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials |
| Q39381894 | Treatment of refractory neuropathic pain related to a brachial plexus injury |
| Q79430529 | Update on adjuvant medications for chronic nonmalignant pain |
| Q37352022 | Update on the pathobiology of neuropathic pain |
| Q33946545 | Use of gabapentin in the treatment of neuropathic pain |
| Q79301277 | Will ion-channel blockers be useful for management of nonneuropathic pain? |
| Q80251113 | [Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch] |
| Q80305420 | [Treatment options in painful diabetic polyneuropathy] |
Search more.